ConductScience.org, home

Paper4176

The pH dependence of quantitative ristocetin-induced platelet aggregation: theoretical and practical implications-a new device for maintenance of platelet-rich plasma pH.

Coller BS and 2 others. Blood, 1976. Cited by 74 papers, by iCite.

Cite this record

ConductScience Library. The pH dependence of quantitative ristocetin-induced platelet aggregation: theoretical and practical implications-a new device for maintenance of platelet-rich plasma pH. Papers, record 4176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4176

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The pH dependence of quantitative ristocetin-induced platelet aggregation: theoretical and practical implications-a new device for maintenance of platelet-rich plasma pH.
PubMed
Journal
Blood
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
3.04
iCite
Revised in PubMed
2021-02-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Coller BSB S
2Franza BR JrB R
3Gralnick HRH R

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood PlateletsMajor topic
Hydrogen-Ion ConcentrationMajor topic
PlasmaMajor topic
Platelet AggregationMajor topic
Blood Coagulation Tests
Humans
In Vitro Techniques
Ristocetin
Time Factors

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
35260751Near-infrared photobiomodulation of blood reversibly inhibits platelet reactivity and reduces hemolysis.Sci Rep2022https://conductscience.org/library/papers/35260751PubMed
32844723
First Human Use of RUC-4: A Nonactivating Second-Generation Small-Molecule Platelet Glycoprotein IIb/IIIa (Integrin αIIbβ3) Inhibitor Designed for Subcutaneous Point-of-Care Treatment of ST-Segment-Elevation Myocardial Infarction.
J Am Heart Assoc2020https://conductscience.org/library/papers/32844723PubMed
25092268The platelet: life on the razor's edge between hemorrhage and thrombosis.Transfusion2014https://conductscience.org/library/papers/25092268PubMed
7406554The role of platelet aggregation and release in fragment D-induced pulmonary dysfunction.Ann Surg1980https://conductscience.org/library/papers/7406554PubMed
6308050A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.J Clin Invest1983https://conductscience.org/library/papers/6308050PubMed
6243142Effect of heparin and heparin fractions on platelet aggregation.J Clin Invest1980https://conductscience.org/library/papers/6243142PubMed
3155324Platelet function and factor VIII in uremia.Korean J Intern Med1987https://conductscience.org/library/papers/3155324PubMed
2991335A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.J Clin Invest1985https://conductscience.org/library/papers/2991335PubMed
565300Destruction of the platelet aggregating activity of ristocetin A.Experientia1978https://conductscience.org/library/papers/565300PubMed
307560Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.J Clin Invest1978https://conductscience.org/library/papers/307560PubMed
307006The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.J Clin Invest1978https://conductscience.org/library/papers/307006PubMed
108291Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.J Clin Invest1979https://conductscience.org/library/papers/108291PubMed
17620Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin.J Clin Invest1977https://conductscience.org/library/papers/17620PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
VWF7450PubTator's text mininghttps://conductscience.org/library/genes/7450

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4176

GET https://conductscience.org/api/papers/v1/4176/authors